• University of Birmingham Featured PhD Programmes
  • FindA University Ltd Featured PhD Programmes
  • Coventry University Featured PhD Programmes
  • University of Manchester Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • Ross University School of Veterinary Medicine Featured PhD Programmes
Ludwig-Maximilians-Universität Munich Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
Imperial College London Featured PhD Programmes
Coventry University Featured PhD Programmes
University of Reading Featured PhD Programmes

Anti-inflammatory peptides

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Prof Jim Middleton
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

About This PhD Project

Project Description

Inflammatory diseases are characterised by the migration of leukocytes into the affected tissue. This is caused by chemokines. By targeting interactions of chemokines with endothelial cells using small peptides and larger molecules we have been able to inhibit leukocyte migration. The project will continue on with this work to design small and large peptides that could be future anti-inflammatory therapies. This will be using cell culture, cell biology, inflammation assays in vitro and potentially in vivo.

When applying please select "PhD in Oral and Dental Sciences" within the Faculty of Health Sciences.

References

Kehoe O, Kalia N, Boyes C, King S, Reizes O, Williams A, Patterson A, Middleton J (2014) Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice. Arthritis Research and Therapy 16: R48 (pp1-10)

Whittall C, Kehoe O, King S, Rot A, Patterson A, Middleton J (2013) A chemokine self-presentation mechanism involving endothelial surface microstructure formation. Journal of Immunology 190 (4): 1725-36.


Cookie Policy    X